hydrazine has been researched along with Stroke in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Balloova, A; Chupakhin, O; Dremencov, E; Grinchii, D; Kiss, A; Kochetkov, A; Mach, M; Osacka, J; Paliokha, R; Rantsev, M; Sarapultsev, A; Sarapultsev, P; Sidorova, L; Spasov, A; Vassiliev, P | 1 |
| Maeda, Y; Tamai, Y; Yamamoto, D | 1 |
| Lapeyre-Mestre, M; Montastruc, F; Moulis, G; Nguyen, TT; Palmaro, A | 1 |
| Ahmad, AS; Candelario-Jalil, E; DeMars, KM; Doré, S; Frankowski, JC; Hawkins, KE; Leclerc, JL; Yang, C | 1 |
| Inoue, K; Leng, T; Ueki, T; Xiong, ZG; Yang, T; Zeng, Z | 1 |
| Fu, N; Fu, Y; Shao, J; Shen, F; Xia, W; Yan, A; Yang, X; Zhang, T | 1 |
6 other study(ies) available for hydrazine and Stroke
| Article | Year |
|---|---|
Combined In Silico, Ex Vivo, and In Vivo Assessment of L-17, a Thiadiazine Derivative with Putative Neuro- and Cardioprotective and Antidepressant Effects.
Topics: Animals; Antidepressive Agents; Computer Simulation; Depression; Hippocampus; Hydrazines; Male; Myocardial Infarction; Neurons; Neuroprotective Agents; Protective Agents; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT3; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT3 Receptor Antagonists; Serotonin Plasma Membrane Transport Proteins; Stroke | 2021 |
Eltrombopag-induced recurrent stroke in idiopathic thrombocytopenic purpura.
Topics: Benzoates; Humans; Hydrazines; Purpura, Thrombocytopenic; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Stroke | 2021 |
Signal for Thrombosis with Eltrombopag and Romiplostim: A Disproportionality Analysis of Spontaneous Reports Within VigiBase®.
Topics: Adverse Drug Reaction Reporting Systems; Aging; Benzoates; Humans; Hydrazines; Myocardial Infarction; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Risk Factors; Stroke; Thrombopoietin; Thrombosis | 2015 |
Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke.
Topics: Animals; Blood-Brain Barrier; Brain Infarction; Disease Models, Animal; Endothelial Cells; Gene Expression; Gene Knockout Techniques; Hydrazines; Male; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Mice; Mice, Knockout; Neurons; Neutrophil Infiltration; Oxazepines; Permeability; Proteolysis; Rats; Receptors, Prostaglandin E, EP1 Subtype; Stroke; Tight Junction Proteins | 2015 |
Role of serum- and glucocorticoid-inducible kinases in stroke.
Topics: Animals; Benzamides; Glucocorticoids; Hydrazines; Immediate-Early Proteins; Infarction, Middle Cerebral Artery; Male; Mice, Inbred C57BL; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Stroke; Ubiquitin-Protein Ligases | 2016 |
Thromboxane A2 receptor antagonist SQ29548 reduces ischemic stroke-induced microglia/macrophages activation and enrichment, and ameliorates brain injury.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Cytokines; Disease Models, Animal; Fatty Acids, Unsaturated; Gliosis; Hydrazines; Macrophage Activation; Mice, Inbred ICR; Receptors, Thromboxane A2, Prostaglandin H2; Reperfusion Injury; Stroke; Treatment Outcome | 2016 |